245 (Imatinib Mesylate 400 mg)
Pill with imprint 245 is Yellow, Elliptical/Oval and has been identified as Imatinib Mesylate 400 mg. It is supplied by Zydus Pharmaceuticals (USA) Inc.
Imatinib is used in the treatment of chronic myelogenous leukemia; dermatofibrosarcoma protuberans; chronic eosinophilic leukemia; acute lymphoblastic leukemia; gastrointestinal stromal tumor and belongs to the drug class BCR-ABL tyrosine kinase inhibitors. There is positive evidence of human fetal risk during pregnancy. Imatinib 400 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for 245
Imatinib Mesylate
- Imprint
- 245
- Strength
- 400 mg
- Color
- Yellow
- Shape
- Elliptical/Oval
- Availability
- Prescription only
- Drug Class
- BCR-ABL tyrosine kinase inhibitors
- Pregnancy Category
- D - Positive evidence of risk
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Zydus Pharmaceuticals (USA) Inc.
- Manufacturer
- Cadila Healthcare Limited
- National Drug Code (NDC)
- 70771-1395
Related Images for "245"
More about imatinib
- Side effects
- Drug interactions
- Dosage information
- During pregnancy or Breastfeeding
- Reviews (40)
- Drug images
- Pricing & coupons
- En español
- Drug class: BCR-ABL tyrosine kinase inhibitors
Patient resources
- Other brands
- Gleevec
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.